AEGiS-UPI: Multivitamin may help mothers with HIV United Press InternationalImportant note: Information in this article was accurate in 1998. The state of the art may have changed since the publication date.
Click here to return to United Press International main menu
DonateNow
Print this article




Multivitamin may help mothers with HIV

United Press International; Thursday May 14 9:21 PM EDT
Meta L. Levin, UPI Science News


WASHINGTON, May 15 (UPI) - Daily doses of a multivitamin may offer a low-cost way to reduce risks to babies as well as improve the health of HIV positive mothers.

In a new study, researchers found the multivitamin not only reduced fetal deaths, low birth-weight and severe preterm births, but improved the mother's health as well.

The team of researchers from the Harvard School of Public Health in Boston and the Muhimili University College of Health Sciences in Dar es Salaam, Tanzania, published their work in the British medical journal The Lancet.

Nearly 13 percent of mothers in Tanzania and up to 30 percent of those in neighboring countries are HIV positive.

Dr. Wafaie W. Fawzi, assistant professor of international nutrition at the Harvard School of Public Health and lead author on the study, said: "The idea of this study was to determine whether an inexpensive intervention would have at least some protective effect. The cost is reasonably attractive compared to other interventions."

Newly developed combination antiviral therapies for HIV/AIDS are expensive. HIV-infected pregnant women have higher risks than uninfected women of fetal deaths, low birth-weight babies, preterm birth and slow fetal growth. The babies also are at higher risk for HIV infection, with greater infant mortality among both infected and uninfected children.

The 1,075 women in the study all came to a government clinic, and all were between 12 and 27 weeks pregnant.

They were divided into four groups: those who received a placebo; those who only received vitamin A; those who received a multivitamin excluding vitamin A; and those receiving a multivitamin including vitamin A. All the groups received daily doses of iron and folate supplements and weekly doses of prophylactic antimalarial medication, which is standard prenatal care in Tanzania.

Previous studies have focused on vitamin A, which was shown in this study not to have an effect. Those receiving multivitamins had approximately 40 percent fewer fetal deaths, low birth-weight babies, or severe preterm births. Researchers also found the multivitamins significantly improved the mother's immune status. Fawzi said, "The improvement in the immune status was sustained after delivery." Multivitamins used in the study had slightly higher amounts of B vitamins (1,2, 6 and 12), folate, C and E than those commonly available in over-the-counter vitamin preparations. He said this was done because those infected with HIV typically have a lower nutrient absorption rate.

All the pregnant HIV-positive women are now on multivitamins and are being tracked to learn if the supplements resulted in an improvement in their clinical condition. The babies also will be tested to learn if HIV transmission from the mothers is reduced. That information is expected within a year. Long-term HIV transmission results from the babies may be hard to interpret since most of the women breastfeed their babies.

Officials followed the World Health Organization code in informing the women of the possible risks of nursing an infant while HIV positive, but most cannot afford baby formula. They felt the benefits of breastfeeding outweighed possible negative affects, Fawzi said.


980514
UP980504


Copyright © 1998 - United Press International. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through United Press International, Permissions Desk, 1510 H St. N.W. Washington DC 2005. Main Phone Switchboard: 202-898-8000 FAX: 202-898-8057 or 202-898-8147 Email: info@upi.com.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Elton John AIDS Foundation UK, the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.

Always watch for outdated information. This article first appeared in 1998. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1998. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .